<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hara H</submitter><funding>NIDDK NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIAMS NIH HHS</funding><pagination>1651-1664.e14</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6294477</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>175(6)</volume><pubmed_abstract>The activator and composition of the NLRP6 inflammasome remain poorly understood. We find that lipoteichoic acid (LTA), a molecule produced by Gram-positive bacteria, binds and activates NLRP6. In response to cytosolic LTA or infection with Listeria monocytogenes, NLRP6 recruited caspase-11 and caspase-1 via the adaptor ASC. NLRP6 activation by LTA induced processing of caspase-11, which promoted caspase-1 activation and interleukin-1? (IL-1?)/IL-18 maturation in macrophages. Nlrp6-/- and Casp11-/- mice were less susceptible to L. monocytogenes infection, which was associated with reduced pathogen loads and impaired IL-18 production. Administration of IL-18 to Nlrp6-/- or Casp11-/- mice restored the susceptibility of mutant mice to L. monocytogenes infection. These results reveal a previously unrecognized innate immunity pathway triggered by cytosolic LTA that is sensed by NLRP6 and exacerbates systemic Gram-positive pathogen infection via the production of IL-18.</pubmed_abstract><journal>Cell</journal><pubmed_title>The NLRP6 Inflammasome Recognizes Lipoteichoic Acid and Regulates Gram-Positive Pathogen Infection.</pubmed_title><pmcid>PMC6294477</pmcid><funding_grant_id>F32 CA200144</funding_grant_id><funding_grant_id>R01 AI063331</funding_grant_id><funding_grant_id>R01 AR055398</funding_grant_id><funding_grant_id>R01 CA166879</funding_grant_id><funding_grant_id>R01 DK091191</funding_grant_id><funding_grant_id>R37 AI063331</funding_grant_id><pubmed_authors>Seregin SS</pubmed_authors><pubmed_authors>Chamaillard M</pubmed_authors><pubmed_authors>Hara H</pubmed_authors><pubmed_authors>Nunez G</pubmed_authors><pubmed_authors>Yang D</pubmed_authors><pubmed_authors>Fukase K</pubmed_authors><pubmed_authors>Inohara N</pubmed_authors><pubmed_authors>Alnemri ES</pubmed_authors><pubmed_authors>Chen GY</pubmed_authors></additional><is_claimable>false</is_claimable><name>The NLRP6 Inflammasome Recognizes Lipoteichoic Acid and Regulates Gram-Positive Pathogen Infection.</name><description>The activator and composition of the NLRP6 inflammasome remain poorly understood. We find that lipoteichoic acid (LTA), a molecule produced by Gram-positive bacteria, binds and activates NLRP6. In response to cytosolic LTA or infection with Listeria monocytogenes, NLRP6 recruited caspase-11 and caspase-1 via the adaptor ASC. NLRP6 activation by LTA induced processing of caspase-11, which promoted caspase-1 activation and interleukin-1? (IL-1?)/IL-18 maturation in macrophages. Nlrp6-/- and Casp11-/- mice were less susceptible to L. monocytogenes infection, which was associated with reduced pathogen loads and impaired IL-18 production. Administration of IL-18 to Nlrp6-/- or Casp11-/- mice restored the susceptibility of mutant mice to L. monocytogenes infection. These results reveal a previously unrecognized innate immunity pathway triggered by cytosolic LTA that is sensed by NLRP6 and exacerbates systemic Gram-positive pathogen infection via the production of IL-18.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Nov</publication><modification>2020-10-29T14:39:33Z</modification><creation>2020-05-21T19:51:10Z</creation></dates><accession>S-EPMC6294477</accession><cross_references><pubmed>30392956</pubmed><doi>10.1016/j.cell.2018.09.047</doi></cross_references></HashMap>